3rd Quarter 2022 Conference Call
Vyant Bio, Inc. is a leader in drug discovery and preclinical oncology and immuno-oncology services enhancing the development of advanced therapies in precision medicine. Leveraging our expertise, we are looking beyond preclinical services to translational sciences and advanced drug discovery disease models as we position Vyant Bio for financial stability and future growth.
Vyant Bio is focused on extending its history of leading in the innovation of proprietary products and superior services through investments in unique technologies. To achieve this, we have developed a corporate culture that inspires innovation, respects knowledge and fosters leadership. We are actively pursuing strategic actions to further accelerate our growth in the field of drug discovery.
Investor Contact Information
Vyant Bio, Inc.
2370 State Route 70 West
Cherry Hill, NJ 08002
Skyline Corporate Communications Group, LLC
One Rockefeller Plaza, 10th Floor
New York, NY 10020
T: (646) 893-5835 x2
Continental Stock Transfer & Trust Company
Monty Harry, Senior Account Manager
17 Battery Place
New York, NY 10004